People: Genomic Health Inc (GHDX.O)
18 Dec 2013
Dr. Felix J. Baker, Ph.D., is appointed as the Director of Genomic Health, Inc. Dr. Baker’s career as a fund-manager began in 1994 when he co-founded a biotechnology investing partnership with the Tisch Family. Dr. Baker holds a B.S. and a Ph.D. in Immunology from Stanford University, where he also completed two years of medical school. Dr. Baker currently serves as a director of Seattle Genetics, Inc. and Synageva BioPharma Corp., both of which are publicly-traded biotechnology companies. In addition, Dr. Baker previously served as a director of AnorMED Inc., Ardea BioSciences, Inc., ConjuChem, Biotechnologies Inc., Neurogen Corporation and Trimeris, Inc., all of which were publicly-traded companies during Dr. Baker’s service as a director.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|